While commonly associated with young children, RSV (Respiratory Syncytial Virus) also poses a serious yet silent risk to older adults—particularly those over 75, or individuals aged 60–74 with chronic conditions like diabetes, heart disease, or respiratory illnesses.

While commonly associated with young children, RSV (Respiratory Syncytial Virus) also poses a serious yet silent risk to older adults—particularly those over 75, or individuals aged 60–74 with chronic conditions like diabetes, heart disease, or respiratory illnesses.

Complications such as pneumonia (78%) and heart failure (17%) are commonly seen in elderly RSV patients. Fortunately, this risk can be significantly reduced through vaccination.

The RSV vaccine helps lower the chance of infection, severe symptoms, long-term effects, and boosts immunity during peak season.

If you or your loved ones fall into a high-risk group, consult your doctor early—prevention is the best protection.